Sign in
8-K

Current Report

Aardvark Therapeutics, Inc. Filed Acc 0001193125-26-120164

Material agreement

  • Item 1.01 Entry into a material definitive agreement

From the SEC's structured data for this filing

Loading ck0001774857-20260323.htm…